Ependymoma
40% of all cancers spread to the brain
What is an ependymoma?
An ependymoma is a rare type of brain tumour that develops from the ependymal cells that line the passageways containing cerebral spinal fluid. They are therefore found in the walls of the ventricles or the spinal cord central canal.
Read more Show lessAre ependymomas classified as low-grade (benign) or high-grade (malignant) brain tumours?
An ependymoma can be classified as a grade 1 or 2 low-grade (slow-growing) tumour or a grade 3 high-grade (malignant) tumour, usually referred to as anaplastic ependymoma.
Low-grade ependymoma tumours (grade 1 and grade 2) are more common in the spine. High-grade or anaplastic ependymomas (grade 3) occur most often in the brain.
Read more Show lessWhat causes an ependymoma?
Ependymomas develop from ependymal cells, which are a type of glial cell. Glial cells provide the structure around neural cells within the brain, and help to keep the neural cells healthy. When the DNA within an ependymal cell becomes damaged, the cell can replicate itself in an uncontrolled way, without apoptosis. This uncontrolled growth is what leads to the formation of a tumour.
Ependymoma tumours can occur as a result of a genetically inherited condition called neurofibromatosis 2. Find out more about this condition here.
What are the symptoms of an ependymoma?
The symtoms of an ependymoma will depend upon where it has arisen in the brain. Find out more here.
What is the best treatment for ependymoma?
Children and adults with ependymoma respond differently to treatment and therefore tend to be treated in different ways.
Read more Show lessHow will we find a cure for ependymoma?
Research we are funding across all of our Centres of Excellence will help lead towards finding a cure for a wide range of brain tumours.
Our University of Plymouth Low-Grade Brain Tumour Research Centre of Excellence is Europe’s leading research institution for low-grade brain tumours. The teams there have a strong focus on both Neurofibromatosis 2 and brain tumours that have an NF2 gene mutation.
The team of research and clinical experts at our Brain Tumour Research Centre of Excellence at Imperial College, London, work closely with the University of Plymouth Centre of Excellence on certain aspects of research into low-grade brain tumours, including those with an NF2 gene mutation.
Scientists at our Brain Tumour Research Centre of Excellence in the University of Portsmouth also collaborate with the University of Plymouth Centre of Excellence on some aspects of low-grade brain tumour research. They have developed models of the blood-brain barrier that support research into drug therapies for all types of brain tumours.
Pioneering research at our Brain Tumour Research Centre of Excellence at Queen Mary University of London has developed methods of studying stem cells that could potentially transfer across all types of brain tumour.
We also fund BRAIN UK at Southampton University, the country’s only national tissue bank providing crucial access to brain tumour samples for researchers from the archives of clinical neuroscience centres in the UK, effectively covering about 90% of the UK population, which is an essential component in the fight to find a cure for brain tumours.